Yefeng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors (NCT07780539) | Yefeng | 2026-09-01 |
Track Yefeng automatically
Every clearance here is in the API, with alerts when new ones post.